17:10 EST Repare Therapeutics (RPTX) trading resumes
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPTX:
- Repare Therapeutics reports Q3 EPS 8c vs. (81c) last year
- XenoTherapeutics to acquire Repare Therapeutics for $1.82 p/s plus one CVR
- Repare Therapeutics trading halted, news pending
- Repare Therapeutics’ Promising Study on Advanced Solid Tumors: A Closer Look
- Repare Therapeutics price target lowered to $3 from $5 at H.C. Wainwright